A Senate nomination and an acting appointment answer different questions. The nomination identifies whom the President wants to put in the job permanently. An acting appointment identifies who may exercise the office’s authority in the meantime. To decide what a leadership change means for a particular FDA notice or decision, start with the document’s date, the authority it invokes, and the official who took the action.
The Senate nomination record lists Heidi Overton as the nominee for Commissioner of Food and Drugs and records a committee hearing on September 24, 2026. On November 17, 2026, the Associated Press reported that the White House said it had pulled the nomination. The Senate record reviewed for this article still listed the hearing as its latest action. The FDA’s leadership page identifies Kyle Diamantas as acting commissioner.
The discussion that follows is general in scope. It explains how to check authority during an FDA leadership transition and makes no finding about either individual’s authority or the validity of any particular FDA action. For a patient, manufacturer, or other recipient of agency correspondence, the practical distinction is between a change in who holds an office and a change to an instruction, approval, or order that affects you.
I. Who can exercise the FDA commissioner’s authority during a confirmation gap?
A. Check which legal route the acting official is using
Federal law establishes the FDA within the Department of Health and Human Services. Under 21 U.S.C. § 393(d), the President appoints the Commissioner of Food and Drugs with the Senate’s advice and consent. The same provision describes the Secretary’s responsibilities through the commissioner, including overall direction and oversight of the agency. That language establishes the permanent appointment process and describes the office’s responsibilities. To understand temporary service, look separately at the law that authorizes someone to perform the office’s functions during a vacancy.
For federal vacancies covered by the Federal Vacancies Reform Act, 5 U.S.C. § 3345(a) describes three routes. The first assistant to the office ordinarily serves in an acting capacity, subject to statutory time limits. The President can direct a person already serving in another Senate-confirmed office to act. The President can also direct a qualifying officer or employee of the agency to act. For that third route, the law specifies at least 90 days of service in a position in the agency during the preceding 365 days and a pay rate at least as high as the minimum for GS–15. A job title alone leaves those facts unanswered.
The distinction matters when reading an announcement that simply says an official will lead the agency. Identify the date the vacancy began, the acting service start date, and the written designation or other instrument, if publicly available. If the government relies on first-assistant succession, look for the legal source identifying the first assistant and the date that person entered that position. If the government relies on a presidential direction, look for the direction and the qualification it invokes. The agency’s biography can tell you who the agency identifies as acting commissioner, while a designation or succession record can explain how that official entered acting service.
In United States v. Jackson, No. 25-6214 (9th Cir. Aug. 17, 2026), decided August 17, 2026, the United States Court of Appeals for the Ninth Circuit affirmed an order disqualifying a putative acting U.S. attorney from participating in or supervising the prosecutions before it. Applying the federal Vacancies Act in the Nevada cases, the panel held that automatic first-assistant succession did not cover a person put in the first-assistant role after the vacancy without having served under a validly appointed officeholder. The panel also rejected an unrestricted delegation of the vacant office’s powers to one person and dismissed the defendants’ cross-appeals from the denial of their motions to dismiss their indictments. For an FDA document, check the date the first assistant took that position and the date the vacancy began before relying on automatic succession. The decision concerned the U.S. attorney’s office and supplies a way to test the asserted route. The identity and authority of an FDA official require the applicable FDA and HHS records.
A separate question arises if the same person holds an acting role and is nominated for the permanent job. Federal 5 U.S.C. § 3345(b) contains a nomination-related restriction tied to prior first-assistant service and a separate exception for qualifying Senate-confirmed first assistants. Read subsections (a) and (b) together before assessing the role of anyone whose name appears in both records. If the Senate record and the agency leadership page identify different people, keep separate files for the nominee and the acting official. Dates and qualifications attached to one person should stay with that person’s record.
For example, imagine the FDA leadership page lists an acting commissioner and a separate agency notice identifies a center director as the person who signed an action. Save those as two records. The first concerns the person the agency identifies as leading the FDA. The second concerns the official who exercised a defined power in your matter. Look for the authority of the center director as well as any appointment record that actually bears on the signature. If the notice includes a statement about a delegation, copy its reference exactly. That reference gives you something specific to check in the regulation, the delegation instrument, or the administrative record.
Use the same separation when a new nominee is announced. Match the exact title in the Senate record to the position in the agency’s statute. A nomination for a different office within the same department may be unrelated to the vacancy you are researching. If several official documents name different people for the same office, note each record’s date and the role it assigns. A nominee, an acting official, and the person who signed a particular decision may be three different people.
Finally, check 5 U.S.C. § 3347 for the federal exclusivity rule. It recognizes express statutory alternatives for temporary service in a specified office and a recess appointment. General statutory authority to delegate or reassign work does not qualify as an express alternative for filling an office. When a record cites a different succession provision, read its actual wording and check whether it covers this office. A statute about succession at a different federal agency cannot answer that question for the FDA.
B. Put the vacancy, nominations, and agency action on one timeline
Federal 5 U.S.C. § 3346 sets the general timing rules for service under § 3345. Except for a vacancy caused by sickness, the initial period generally runs for up to 210 days from the vacancy. The section also permits service during the pendency of a first or second nomination, subject to its terms. It provides for up to 210 days after a first nomination is rejected, withdrawn, or returned and sets out what can happen with a second nomination, including a period of up to 210 days after the second rejection, withdrawal, or return. The text also provides a different starting point when the vacancy begins during an adjournment of Congress sine die. These periods govern acting service under the statute. They are separate from any response or filing date in your own FDA matter.
Build the timeline from records you can identify. In one row put the date the office became vacant and the source for that date. In another put the date acting service began, the asserted authority, and the source for each. In separate rows put when the first or second nomination was submitted and the disposition recorded for it, if any. In the final row put the date of the agency action you care about. On each row distinguish a date the document records from the date you viewed it. A web page can change after you open it, and a public announcement can precede an entry in a legislative record.
The distinction between announcement and recorded action is especially useful when the question is whether a post-withdrawal period has started. Use the operative date established by the relevant record for the specific nomination. An expected committee vote, the cancellation of a hearing, a press publication date, and an official withdrawal entry describe different events. Compare the nomination number and office across records before putting two dates on the same line. If the readily available record leaves the date uncertain, mark that date as unconfirmed and leave the period uncalculated.
Federal 5 U.S.C. § 3348(c) also addresses the last day of a 210-day period when the Senate is out of session. It treats the second day on which the Senate is next in session and receiving nominations as the last day of the period. That is one reason to save the relevant Senate record before relying on a calendar count. The Government Accountability Office’s Vacancies Act materials list its letters reporting violations of federal acting-service time limits and its decisions when Congress requests a compliance determination. Match any letter you find to the specific office and vacancy.
For example, consider an FDA letter signed during a week in which the news reports that a nomination has been pulled. Record when the agency dated and issued the letter, when you received it, and what the letter asks you to do. Compare the signing date with the public timeline for the official who signed. Keep the instructions on the letter in view while you check the appointment question. If the FDA issues a later instruction for the same matter, save both versions and identify what changed. This lets you ask about a concrete date or document even if the nomination history is still being updated.
II. How can you check whether a specific FDA step was authorized?
A. Match the action to the statute, regulation, and delegation
Begin with the action itself. A webpage update, a news release, a request for information, and a signed final order may all carry the FDA’s name. The source of authority relevant to each can differ. Save the signed document and its attachments. Note the exact title and signature block, document or docket number, relevant product or application number, and the statute or regulation cited. Where a bulletin describes a rule or order, locate the underlying rule or order and record the dates on both. This makes it possible to ask who did what instead of posing a general challenge to agency leadership.
Federal 5 U.S.C. § 3348(a), (b), and (d) supplies an important distinction for a vacancies challenge. For purposes of that section, a function or duty is one that statute or regulation requires the particular officer alone to perform, with a specific lookback for applicable regulations. The section describes when an office remains vacant and, for a covered office other than the head of an executive agency, when only the agency head may perform a function or duty in the absence of authorized acting service. It also provides that action within the provision taken without the required authority has no force or effect and cannot be ratified. Read the section’s exceptions before invoking those consequences. Establishing that a position was vacant and establishing that a particular action falls within § 3348 require different evidence.
In Widakuswara v. Lake, No. 1:25-cv-1015-RCL (D.D.C. Mar. 7, 2026), decided March 7, 2026, the United States District Court for the District of Columbia granted partial summary judgment on federal Vacancies Act and Appointments Clause claims involving the U.S. Agency for Global Media. The court found that the asserted acting service was unauthorized and rejected two broad delegations that transferred nearly all the chief executive’s statutory powers. It held that the challenged reduction-in-force action lacked legal effect. For an FDA matter, compare the scope of the written delegation with the office’s powers and identify the specific action taken under that delegation. This is a district court ruling in a dispute over another agency’s authority. Its result on partial summary judgment concerns the record in that case.
Look for both the scope and effective date of the authority document. A delegation might specify a particular kind of action, an office within a center, or a category of products. A later delegation might change which role can sign. If a document refers to authority previously assigned to another office, trace the assignment to the instrument that was in effect on the relevant date. Save the complete document so the general grant and any exclusions remain together. A short excerpt may omit the limitation that matters for your particular notice.
Ask separately whether the underlying federal law reserves the task to the commissioner personally. Start with the statute or regulation cited in the document, then check definitions and cross-references that identify who may act. Flag language addressing delegation and any provision specific to the type of action. If an FDA center official signs by delegated authority, identify the authority for that action. If the instrument cites the office generally, note the gap in the public record and seek the dated authority rather than inferring it from the official’s biography or title.
B. Distinguish an appointment objection from the remedy for your document
In Gonzales & Gonzales Bonds & Insurance Agency, Inc. v. USDHS, 107 F.4th 1064 (9th Cir. 2024), decided July 18, 2024, the United States Court of Appeals for the Ninth Circuit reversed summary judgment and remanded a federal challenge to a Department of Homeland Security rule affecting immigration bond sureties. The panel concluded that the original official lacked authority to issue the rule. It held that the rulemaking function was delegable and that the Vacancies Act’s ratification bar did not prevent a duly appointed successor from ratifying the rule in that case. For an FDA decision, check whether the exact function was reserved to the commissioner and whether a later official actually took a documented action addressing the earlier decision. The panel’s reasoning concerned the particular DHS rule and the authority available for that rulemaking.
In its August 17, 2026 decision in United States v. Jackson, No. 25-6214 (9th Cir. Aug. 17, 2026), the United States Court of Appeals for the Ninth Circuit cited Gonzales in applying the federal rule that general delegation authority cannot be used to install an acting officer. It explained that § 3348’s definition of a function or duty applies to that section, so it did not carry that definition into its separate analysis of § 3347. For someone evaluating a regulatory decision, this makes the sequence important. First ask whether the official had authority for the role or assignment at issue. Then ask what remedy the law provides for that particular action and whether a later decision changed it. The answers can differ.
If you find a document described as a ratification, check which prior action it identifies, who issued it, what legal authority that official invoked, and what the document actually does. A general statement that operations are continuing tells you little about a specific final decision. If a new rule or order exists, save it with the earlier version and compare the addressed parties, effective dates and operative language. Record whether the later document reissues a decision, changes it, or deals only with a separate step. Those distinctions determine which document you should ask the agency or your adviser to address.
Keep your immediate response separate from the appointment research. A patient who finds conflicting public statements can identify the specific product, lot number, and dated FDA notice so a pharmacist or clinician can put the messages in context. A business with a pending application can preserve its submissions, agency acknowledgments, contact history, and any revised instructions. A recipient of a signed order can compare the operative language on the signed copy with any later communication in the same matter. If a question remains about the agency’s authority, a short chronology and the actual documents make the question more precise than a collection of news links.
A practical file can be organized around four questions. Which decision affects you? Who made it, and in what capacity on that date? Which statute, regulation, designation, or delegation covers that act? Has an agency or court issued a later document specifically addressing it? For each answer, record the source and mark any point the available documents leave open. This helps distinguish a missing public record from a proven defect. It also makes it easier to find the relevant instruction if more than one agency office has communicated with you.
For a hypothetical warning followed by an enforceable order, put both documents in the file and check what each requires. The writer of the warning may have requested a response, while the later order may identify a different decision maker and cite a different source of authority. If your concern is the order, start with the signature and legal basis on that order. Keep the earlier warning because it may explain the background and show what the agency knew, but keep its date and sender separate. The difference can narrow the authority question to the one action with a practical consequence for you.
Before raising the issue in writing, state the missing fact as a question the records could resolve. Ask which designation was in force on the date of the action, which provision covers the signing official’s role, or which later document modified the original one. Include the document number or application reference so the recipient can identify the right file. If the records already answer one question, set that question aside and concentrate on the point that affects what you need to do next.
Finally, take care when using cases from another federal agency. The Ninth Circuit decisions described here address federal statutory questions in disputes before that circuit. The District of Columbia district court opinion analyzes a different agency and the record presented on partial summary judgment. Their value for an FDA reader is that they help identify three different pieces of evidence to look for: the appointment record, the scope of any delegation, and the authority tied to the action and any later decision. A court reviewing an FDA dispute would need the facts and governing provisions for that dispute.
Conclusion
During an FDA confirmation gap, check the acting-service record and the agency document that affects you. On the acting-service side, identify the vacancy date, the route to temporary service, and the relevant nomination history. On the document side, identify the action date, the signing official, and the legal authority for that particular action. Preserve any later decision alongside the original. With those records, you can separate a change in leadership from a change in what the FDA requires in your matter and identify the specific question the records leave unanswered.